Atlas Trials

Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects

Clinical trial NCT05415644 · COMPLETED

Trial details

NCT number
NCT05415644
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2022-07-05
Primary completion
2022-08-08
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.